Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Osteoporosis
Are there any concerns with using denosumab in a patient with chronic hepatitis B infection on antiviral therapy?
Related Questions
Is it safe to combine Prolia with other immunosuppressants?
What treatment options would you consider for a young patient with limited mobility, low bone mass and multiple vertebral compression fractures who is on dialysis for advanced kidney disease?
Which fracture sites outside of the classical spine and hip are considered to be osteoporotic fractures even in the absence of a bone density diagnosis?
How do you manage hepatotoxicity thought to be related to Romosozumab use?
Is elevated bone specific alkaline phosphatase an absolute contraindication to teriparatide?
How should we interpret DXA scans in patients with Ankylosing Spondylitis who have ankylosis of the spine?
How often do you see bony erosions in patients with Lyme arthritis?
Do you recommend initiating immunosuppression and plasmapheresis in patients with dialysis dependent AKI in the setting of anti-GBM disease who do not have pulmonary involvement?
How do you approach using DMARDs for patients with CPP arthritis who have frequent flares?
What is your approach to the management of shrinking lung syndrome in SLE?